Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Boston Scientific Corporation
Boston Scientific Corporation
Pfizer
National Cancer Center Hospital East
Beijing Tsinghua Chang Gung Hospital
Centre Paul Strauss
Brigham and Women's Hospital
IDRx Inc. - A GSK Company
Dartmouth-Hitchcock Medical Center
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lund University Hospital
Pfizer
Hoffmann-La Roche
Thomas Jefferson University
Thomas Jefferson University
Revolution Medicines, Inc.
Boston Scientific Corporation
University of Alberta
Imunon
University of Aarhus
NanOlogy, LLC
Theseus Pharmaceuticals
Duke University
University Medical Center Groningen
OncoSil Medical Limited
Kyowa Kirin Co., Ltd.
Taipei Veterans General Hospital, Taiwan
University Hospital, Antwerp
Catalysis SL
Catalysis SL
Qure Healthcare, LLC
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
The First Affiliated Hospital with Nanjing Medical University
The Second Affiliated Hospital of Fujian Medical University
Celgene
Advanced Endoscopy Research, Robert Wood Johnson Medical School Rutgers University
Catalysis SL
Sociedad Española de Medicina Nuclear e Imagen Molecular
Jiangxi Provincial Cancer Hospital
Revolution Medicines, Inc.
Zhejiang University
State Scientific Centre of Coloproctology, Russian Federation
H. Lee Moffitt Cancer Center and Research Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Cedars-Sinai Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Zhejiang University